PROCEPT生物机器人
PRCT
17.57
-0.58
-3.20%
PROCEPT生物机器人
US · PRCT
#3234 按市值排名
上市于 2021
17.57
-0.58
-3.20%
实时 - 追踪5344个代码 - 心跳于506秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
减持
- 最近一期（2026/Q3）披露持股的机构数量减少了2家。
- 机构持股总比例下降了0.7个百分点。
机构持股
- 机构持股比例
- 98.19% -0.70pp
- 机构数量
- 311 -2
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund76.95%
Hedge Fund11.98%
Public Company3.99%
Individual/Insider2.56%
Private Company1.77%
Government Pension Fund1.70%
VC/PE Fund0.79%
Insurance Company0.60%
Sovereign Wealth Fund0.28%
主要股东 截至 2026-06-30
BlackRock
8.50% · 4.87M 股
T. Rowe Price Group, Inc.
8.03% · 4.60M 股
Vanguard Capital Management, LLC
5.00% · 2.86M 股
Vanguard Portfolio Management, LLC
4.41% · 2.53M 股
Chicago Capital, LLC
3.62% · 2.07M 股
State Street Global Advisors
2.82% · 1.62M 股
Geode Capital Management, LLC
2.59% · 1.48M 股
FMR
2.52% · 1.44M 股
BNPP Asset Management Holding
2.50% · 1.43M 股
Wellington Management Group
2.22% · 1.27M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 34次买入 · 11次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Frederic Moll | Independent Chairperson | 1.51% |
| Barry Templin | Senior Vice President of Medical Affairs & Market Access | 0.26% |
| Taylor Harris | Independent Director | 0.23% |
| Kevin Waters | Chief Financial Officer | 0.14% |
| Reza Zadno | Chief Executive Officer | 0.12% |
| Antal Desai | Independent Director | 0.09% |
| Alaleh Nouri | EVP, Chief Legal Officer & Corporate Secretary | 0.07% |
| Larry Wood | Independent Director | 0.05% |
| Hisham Shiblaq | Executive Vice President | 0.03% |
| Mary Garrett | Independent Director | 0.03% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-10-01 | Michael Mack | Independent Director | Other Acquisition | +7,727 | -- |
| 2026-10-01 | Michael Mack | Independent Director | Other Derivative Acquisition | +12,191 | $17.16 |
| 2026-09-08 | Alaleh Nouri | EVP, Chief Legal Officer & Corporate Secretary | Open Market Disposition | -297 | $20.95 |
| 2026-09-08 | Barry Templin | Senior Vice President of Medical Affairs & Market Access | Open Market Disposition | -373 | $20.95 |
| 2026-09-08 | Kevin Waters | Chief Financial Officer | Open Market Disposition | -373 | $20.95 |
| 2026-08-12 | Alaleh Nouri | EVP, Chief Legal Officer & Corporate Secretary | Other Acquisition | +22,965 | -- |
| 2026-08-12 | Alaleh Nouri | EVP, Chief Legal Officer & Corporate Secretary | Other Derivative Acquisition | +31,773 | $21.95 |
| 2026-08-12 | Barry Templin | Senior Vice President of Medical Affairs & Market Access | Other Acquisition | +26,246 | -- |
| 2026-08-12 | Barry Templin | Senior Vice President of Medical Affairs & Market Access | Other Derivative Acquisition | +36,312 | $21.95 |
| 2026-08-12 | Kevin Waters | Chief Financial Officer | Other Acquisition | +29,527 | -- |
| 2026-08-12 | Kevin Waters | Chief Financial Officer | Other Derivative Acquisition | +40,851 | $21.95 |
| 2026-08-12 | Pooja Sharma | -- | Other Acquisition | +23,622 | -- |
| 2026-08-12 | Pooja Sharma | -- | Other Derivative Acquisition | +32,681 | $21.95 |
| 2026-08-06 | Larry Wood | Independent Director | Open Market Acquisition | +23,900 | $20.85 |
| 2026-06-08 | Thomas Prescott | Chairperson of the Board | Other Acquisition | +3,315 | -- |
| 2026-06-08 | Thomas Prescott | Chairperson of the Board | Other Derivative Acquisition | +5,853 | $28.78 |
| 2026-06-08 | Frederic Moll | Independent Chairperson | Other Acquisition | +3,315 | -- |
| 2026-06-08 | Frederic Moll | Independent Chairperson | Other Derivative Acquisition | +5,853 | $28.78 |
| 2026-06-08 | Taylor Harris | Independent Director | Other Acquisition | +3,315 | -- |
| 2026-06-08 | Taylor Harris | Independent Director | Other Derivative Acquisition | +5,853 | $28.78 |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:05 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
PROCEPT生物机器人 讨论区 0 条评论